RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+6.66%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$328M
AUM Growth
+$328M
(+31%)
Cap. Flow
+$74.7M
Cap. Flow
% of AUM
22.76%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
103
New
20
Increased
33
Reduced
37
Closed
13
Top Buys
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Gilead Sciences
GILD
|
$9.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.39M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.73M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.64M |
Top Sells
| 1 |
Innoviva
INVA
|
$4.71M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$3.73M |
| 3 |
Intuitive Surgical
ISRG
|
$3.07M |
| 4 |
Zimmer Biomet
ZBH
|
$2.8M |
| 5 |
AET
Aetna Inc
AET
|
$2.74M |
Sector Composition
| 1 | Healthcare | 80.94% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Hologic
HOLX
$14.7B
| – | – |
-72,000
| Closed | -$1.61M |
|
102
Agilent Technologies
A
$35.5B
| – | – |
-40,000
| Closed | -$2.29M |
|